Pfizer Inc. (PFE) - Income Statement

Home
PFE
Financials

29.66 (USD) • At close September 19, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002	2001	2000	1999	1998	1997	1996	1995	1994	1993	1992	1991	1990	1989	1988	1987	1986	1985
Revenue Numbers are in millions	58,496	100,330	81,288	41,908	51,750	53,647	52,546	52,824	48,851	49,605	51,584	58,986	67,425	67,809	50,009	48,296	48,418	48,371	51,298	52,516	45,188	32,373	32,259	29,574	16,204	13,544	12,504	11,306	10,021.4	8,281.3	7,477.7	7,230.2	6,950	6,406	5,671.5	5,385.4	4,919.8	4,476	4,024.5
Cost of Revenue Numbers are in millions	29,213	34,344	30,821	8,692	10,219	11,248	11,240	12,329	9,648	9,577	9,586	11,334	15,085	16,279	8,888	8,112	11,239	7,640	8,525	7,541	9,832	4,045	5,034	4,059	1,986	1,605	1,772	1,746	1,790.1	1,626.6	1,513.8	1,760.4	1,956.5	2,034.6	1,855.2	1,825.6	1,734.9	1,573.3	1,416.2
Gross Profit Numbers are in millions	29,283	65,986	50,467	33,216	41,531	42,399	41,306	40,495	39,203	40,028	41,998	47,652	52,340	51,530	41,121	40,184	37,179	40,731	42,773	44,975	35,356	28,328	27,225	25,515	14,218	11,939	10,732	9,560	8,231.3	6,654.7	5,963.9	5,469.8	4,993.5	4,371.4	3,816.3	3,559.8	3,184.9	2,902.7	2,608.3
Gross Profit Ratio Numbers are in millions	0.501	0.658	0.621	0.793	0.803	0.79	0.786	0.767	0.803	0.807	0.814	0.808	0.776	0.76	0.822	0.832	0.768	0.842	0.834	0.856	0.782	0.875	0.844	0.863	0.877	0.881	0.858	0.846	0.821	0.804	0.798	0.757	0.718	0.682	0.673	0.661	0.647	0.649	0.648
Reseach & Development Expenses Numbers are in millions	10,578	11,428	13,829	9,405	8,650	8,006	7,657	7,872	7,690	8,393	6,678	7,870	9,112	9,413	7,845	7,945	8,089	7,599	7,442	7,684	7,131	5,176	4,847	4,435	2,776	2,279	1,928	0	0	0	0	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	10,770	10,877	10,703	9,815	12,050	11,755	11,684	11,637	11,709	10,997	11,355	13,816	0	0	0	0	0	0	0	0	0	0	11,299	11,442	6,351	5,568	4,956	6,050	5,297.1	4,390.2	0	0	0	0	0	0	0	0	0
Selling & Marketing Expenses Numbers are in millions	3,700	2,800	2,000	1,800	2,300	2,700	3,100	3,200	3,100	3,100	3,000	2,800	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	14,470	13,677	12,703	11,615	14,350	14,455	14,784	14,837	14,809	14,097	14,355	16,616	19,468	19,614	14,875	14,537	15,626	15,589	16,997	16,903	15,242	10,846	11,299	11,442	6,351	5,568	4,956	6,050	5,297.1	4,390.2	4,792.4	3,762.5	3,495.9	3,092.8	2,641	2,353.4	2,082.1	1,795.9	1,598.8
Other Expenses Numbers are in millions	2,670	3,609	3,700	3,436	4,610	1,140	981	820	519	1,267	558	-4,031	5,585	8,345	2,682	2,668	3,128	3,261	3,409	3,364	2,183	28	103	968	542	489	502	430	374	292	258.2	263.9	244.1	224.8	207.1	194.5	162	147.1	129.5
Operating Expenses Numbers are in millions	25,048	28,714	30,232	24,456	27,610	27,354	27,199	26,765	26,227	26,529	25,632	29,661	34,165	37,372	25,889	25,150	26,843	26,449	27,848	27,951	24,556	16,050	16,249	16,845	9,669	8,336	7,386	6,480	5,671.1	4,682.2	5,050.6	4,026.4	3,740	3,317.6	2,848.1	2,547.9	2,244.1	1,943	1,728.3
Operating Income Numbers are in millions	4,235	40,030	24,833	10,630	15,137	15,045	14,107	13,730	12,976	13,499	16,366	17,991	18,175	14,158	15,651	15,034	10,336	14,282	14,925	17,024	10,800	12,278	10,976	8,670	4,549	3,603	3,346	3,080	2,560.2	1,972.5	913.3	1,443.4	1,253.5	1,053.8	968.2	1,011.9	940.8	959.7	880
Operating Income Ratio Numbers are in millions	0.072	0.399	0.305	0.254	0.293	0.28	0.268	0.26	0.266	0.272	0.317	0.305	0.27	0.209	0.313	0.311	0.213	0.295	0.291	0.324	0.239	0.379	0.34	0.293	0.281	0.266	0.268	0.272	0.255	0.238	0.122	0.2	0.18	0.165	0.171	0.188	0.191	0.214	0.219
Total Other Income Expenses Net Numbers are in millions	-3,177	-5,301	-522	-3,133	2,545	-2,178	-923	-4,663	-3,282	-325	361	-5,911	-5,413	-3,339	-4,405	-6,112	-2,157	-1,691	-3,660	-3,016	-7,613	-613	-920	-3,061	-101	-1,009	-258	-276	-261	-111	44.6	194.8	-179.7	182	74.3	174.4	133.4	60.7	79.8
Income Before Tax Numbers are in millions	1,058	34,729	24,311	7,497	17,682	11,885	12,305	8,351	8,965	12,240	15,716	12,080	12,762	9,422	10,827	9,694	9,278	13,028	11,534	14,007	3,263	11,796	10,329	5,767	4,443	2,592	3,078	2,798	2,292.2	1,856.9	848.8	1,532.1	940.5	1,099.1	912.4	1,100.7	1,007.5	960.7	876.1
Income Before Tax Ratio Numbers are in millions	0.018	0.346	0.299	0.179	0.342	0.222	0.234	0.158	0.184	0.247	0.305	0.205	0.189	0.139	0.217	0.201	0.192	0.269	0.225	0.267	0.072	0.364	0.32	0.195	0.274	0.191	0.246	0.247	0.229	0.224	0.114	0.212	0.135	0.172	0.161	0.204	0.205	0.215	0.218
Income Tax Expense Numbers are in millions	-1,114	3,328	1,852	477	1,384	706	-9,049	1,123	1,990	3,120	4,306	2,562	4,023	1,124	1,645	1,645	1,023	1,992	3,424	2,665	1,621	2,609	2,561	2,049	1,244	642	865	869	738	558.5	191.3	438.6	218.4	297.9	231.3	309.4	317.3	300.7	296.4
Net Income Numbers are in millions	2,119	31,372	21,979	7,020	16,273	11,153	21,308	7,215	6,960	9,135	22,003	14,570	10,009	8,257	8,635	8,104	8,144	19,337	8,085	11,361	3,910	9,126	7,788	3,726	3,179	3,351	2,213	1,929	1,572.9	1,298.4	657.5	810.9	722.1	801.2	681.1	791.3	690.2	660	579.7
Net Income Ratio Numbers are in millions	0.036	0.313	0.27	0.168	0.314	0.208	0.406	0.137	0.142	0.184	0.427	0.247	0.148	0.122	0.173	0.168	0.168	0.4	0.158	0.216	0.087	0.282	0.241	0.126	0.196	0.247	0.177	0.171	0.157	0.157	0.088	0.112	0.104	0.125	0.12	0.147	0.14	0.147	0.144
EPS Numbers are in millions	0.38	5.59	3.95	1.26	2.92	1.9	3.57	1.18	1.13	1.44	3.23	1.96	1.28	1.03	1.23	1.2	1.18	2.67	1.1	1.51	0.54	1.48	1.25	0.6	0.81	0.76	0.58	0.52	0.42	0.35	0.17	0.21	0.19	0.21	0.16	0.19	0.17	0.16	0.14
EPS Diluted Numbers are in millions	0.38	5.47	3.88	1.25	2.87	1.87	3.52	1.17	1.11	1.42	3.19	1.94	1.27	1.02	1.23	1.2	1.17	2.66	1.09	1.49	0.54	1.46	1.22	0.59	0.78	0.73	0.56	0.5	0.42	0.35	0.17	0.2	0.18	0.21	0.16	0.19	0.17	0.16	0.14
EBITDA Numbers are in millions	10,525	43,639	28,533	14,066	19,747	21,412	20,237	19,076	17,693	19,231	21,926	25,046	29,173	23,047	22,514	26,236	17,693	21,266	24,161	25,133	22,491	13,927	12,964	12,699	5,192	5,101	4,106	3,786	3,195.2	2,375.5	1,126.9	1,512.5	1,677.3	1,096.6	1,101	1,032	969.4	1,046.1	929.7
EBITDA Ratio Numbers are in millions	0.18	0.435	0.351	0.336	0.382	0.399	0.385	0.361	0.362	0.388	0.425	0.425	0.433	0.34	0.45	0.543	0.365	0.44	0.471	0.479	0.498	0.43	0.402	0.429	0.32	0.377	0.328	0.335	0.319	0.287	0.151	0.209	0.241	0.171	0.194	0.192	0.197	0.234	0.231

Pfizer Inc.

NYSE:PFE Add to watchlist

NYSE:PFE